Wird geladen...
A 12-week prospective randomized controlled comparative trial of vilazodone and sertraline in Indian patients with depression
BACKGROUND: Depressive disorders are considered to be one of the leading causes of morbidity and mortality accounting for 4.3% of total disability-adjusted life years. Selective serotonin reuptake inhibitors and serotonin–norepinephrine reuptake inhibitors have greater efficacy and lesser side effec...
Gespeichert in:
| Veröffentlicht in: | Indian J Pharmacol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wolters Kluwer - Medknow
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7074431/ https://ncbi.nlm.nih.gov/pubmed/32201441 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijp.IJP_618_18 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|